Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V E Groppi

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecular and Cellular Biology|November 1, 1988
Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogeneA H Lin, V E Groppi, R R Gorman
Molecular Pharmacology|May 1, 1981
An Mr = 52,000 peptide can mediate effects on cholera toxin on adenylate cyclase in intact cellsH R Kaslow, D Cox, V E Groppi, et al.
The Journal of Cell Biology|November 1, 1981
Cholera toxin can catalyze ADP-ribosylation of cytoskeletal proteinsH R Kaslow, V E Groppi, M E Abood, et al.
The Journal of Biological Chemistry|August 25, 1983
Identification by direct photoaffinity labeling of an altered phosphodiesterase in a mutant S49 lymphoma cellV E Groppi, F Steinberg, H R Kaslow, et al.
Nature|December 11, 1997
Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channelsD Spanswick, M A Smith, V E Groppi, et al.
Psychopharmacology|September 11, 2001
The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?B Olivier, C Leahy, T Mullen, et al.
Journal of Cellular Physiology|September 1, 1987
Phorbol myristate acetate inhibits growth in S49 cells: isolation of resistant variantsK L Leach, E A Powers, J K Mayo, et al.
Development (Cambridge, England)|April 1, 1991
Localization of TIMP in cycling mouse hairT T Kawabe, T J Rea, A M Flenniken, et al.
British Journal of Cancer|September 1, 1990
P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotypeG J Badiner, B C Moy, K S Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Limitation of myocardial injury with the potassium channel opener cromakalim and the nonvasoactive analog U-89,232: vascular vs. cardiac actions in vitro and in vivoC F Toombs, N R Norman, V E Groppi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Biology|November 1, 1988
Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogeneA H Lin, V E Groppi, R R Gorman
Molecular Pharmacology|May 1, 1981
An Mr = 52,000 peptide can mediate effects on cholera toxin on adenylate cyclase in intact cellsH R Kaslow, D Cox, V E Groppi, et al.
The Journal of Cell Biology|November 1, 1981
Cholera toxin can catalyze ADP-ribosylation of cytoskeletal proteinsH R Kaslow, V E Groppi, M E Abood, et al.
The Journal of Biological Chemistry|August 25, 1983
Identification by direct photoaffinity labeling of an altered phosphodiesterase in a mutant S49 lymphoma cellV E Groppi, F Steinberg, H R Kaslow, et al.
Nature|December 11, 1997
Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channelsD Spanswick, M A Smith, V E Groppi, et al.
Psychopharmacology|September 11, 2001
The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?B Olivier, C Leahy, T Mullen, et al.
Journal of Cellular Physiology|September 1, 1987
Phorbol myristate acetate inhibits growth in S49 cells: isolation of resistant variantsK L Leach, E A Powers, J K Mayo, et al.
Development (Cambridge, England)|April 1, 1991
Localization of TIMP in cycling mouse hairT T Kawabe, T J Rea, A M Flenniken, et al.
British Journal of Cancer|September 1, 1990
P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotypeG J Badiner, B C Moy, K S Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Limitation of myocardial injury with the potassium channel opener cromakalim and the nonvasoactive analog U-89,232: vascular vs. cardiac actions in vitro and in vivoC F Toombs, N R Norman, V E Groppi, et al.
Pageof 3